HCPCS Level II code C1820 denotes an implantable neurostimulator generator with a rechargeable battery and charging system. This durable medical equipment code covers the implanted power unit that enables long-term neurostimulation therapies for conditions such as chronic pain, movement disorders, and certain neurological syndromes. Nationally, reimbursement and coverage for implantable neurostimulators are important because they affect access to advanced neuromodulation treatments and the total cost of episodic surgical management.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, and the clinical context for use. The publication summarizes payer coverage considerations and common billing modifiers used with implantable device supply and implantation service lines. It also provides benchmarking context for device-class billing and highlights policy updates relevant to device coding and reimbursement.

This summary equips clinicians, billing professionals, and policy analysts with the essential background on HCPCS Level II code C1820, what to expect in payer interactions, and where to look for further detail on clinical indications and coding nuances. Data not available in the input regarding associated taxonomies, specific ICD-10 diagnoses, and related codes.